HESTER BIOSCIENCES LTD.

NSE : HESTERBIOBSE : 524669ISIN CODE : INE782E01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE1658.65-22.1 (-1.31 %)
PREV CLOSE ( ) 1680.75
OPEN PRICE ( ) 1669.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 774
TODAY'S LOW / HIGH ( )1651.00 1680.00
52 WK LOW / HIGH ( )1292.9 1928.45
NSE1660.70-23.8 (-1.41 %)
PREV CLOSE( ) 1684.50
OPEN PRICE ( ) 1659.25
BID PRICE (QTY) 1660.70 (20)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11634
TODAY'S LOW / HIGH( ) 1649.00 1680.65
52 WK LOW / HIGH ( )1292.85 1939.95
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax401.54535.02501.03413.26568.56
Adjustment123.87110.99203.41201.28179.23
Changes In working Capital-208.38-387.8015.45-137.46-122.56
Cash Flow after changes in Working Capital317.03258.21719.89477.08625.22
Cash Flow from Operating Activities235.9687.12580.53367.72467.08
Cash Flow from Investing Activities-769.99-1165.88-383.72-744.73-217.28
Cash Flow from Financing Activities417.581115.36-182.19187.4326.51
Net Cash Inflow / Outflow-116.4536.6014.62-189.58276.32
Opening Cash & Cash Equivalents247.50212.69235.31406.47123.27
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANA6.88
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations0.51-1.79-37.2418.42NA
Closing Cash & Cash Equivalent131.56247.50212.69235.31406.47

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.